Your browser doesn't support javascript.
loading
A Comparison of Clinical Outcomes After Total Knee Arthroplasty in Patients Who Have and Do Not Have Self-Reported Nickel Allergy: Matched and Unmatched Cohort Comparisons.
Siljander, Breana R; Chandi, Sonia K; Cororaton, Agnes D; Debbi, Eytan M; McLawhorn, Alexander S; Sculco, Peter K; Chalmers, Brian P.
Afiliación
  • Siljander BR; Hospital for Special Surgery, New York, New York.
  • Chandi SK; Hospital for Special Surgery, New York, New York.
  • Cororaton AD; Hospital for Special Surgery, New York, New York.
  • Debbi EM; Hospital for Special Surgery, New York, New York.
  • McLawhorn AS; Hospital for Special Surgery, New York, New York.
  • Sculco PK; Hospital for Special Surgery, New York, New York.
  • Chalmers BP; Hospital for Special Surgery, New York, New York.
J Arthroplasty ; 2024 May 15.
Article en En | MEDLINE | ID: mdl-38759819
ABSTRACT

BACKGROUND:

The impact of a preoperative self-reported nickel allergy in patients undergoing primary total knee arthroplasty (TKA) remains unclear. The aim of this study was to compare the revision rates and outcomes of patients who have a self-reported nickel allergy undergoing primary TKA to patients who do not have a self-reported nickel allergy.

METHODS:

Over 5 years, a total of 284 TKAs in patients who have and 17,735 in patients who do not have a self-reported nickel allergy were performed. Revision rates and differences in preoperative and postoperative patient-reported outcome measures, including Knee Osteoarthritis Outcome Score Joint Replacement (KOOS JR), Visual Analog Scale, Lower Extremity Activity Scale, and the Patient-Reported Outcomes Measurement Information System Mental and Physical Scores, were compared.

RESULTS:

Survivorship free of all-cause revision at 1 year was similar for patients who have and do not have a self-reported nickel allergy (99.5% [95% CI (confidence interval) 98.6 to 100.0] versus 99.3% [95% CI 99.1 to 99.4]), P = .49). Patients who have a self-reported nickel allergy undergoing primary TKA had no difference in KOOS JR, Visual Analog Scale, or Lower Extremity Activity Scale scores at 6 weeks and 1 year and slightly worse Patient-Reported Outcomes Measurement Information System mental and physical scores at 6 weeks compared to patients who did not have an allergy. Matched analysis revealed no difference in 6-week or 1-year KOOS, JR scores between patients who did and did not have a self-reported nickel allergy when stratified by implant class (nickel-free versus standard cobalt-chromium) (P = .113 and P = .415, respectively).

CONCLUSIONS:

Patients who have a self-reported nickel allergy can be advised that, on average, their clinical outcome scores will improve similarly to patients who do not have a self-reported nickel allergy, and revision rates will be similar.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Arthroplasty Asunto de la revista: ORTOPEDIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Arthroplasty Asunto de la revista: ORTOPEDIA Año: 2024 Tipo del documento: Article